Antibe Therapeutics is a biotech company that develops therapeutics and medical devices for pain, inflammation, and regenerative medicine. Their drugs aim to prevent gastrointestinal damage caused by anti-inflammatory drugs. Their lead compound, Otenaproxesul, treats various conditions and has completed a Phase 2B study. They also have a product in the preclinical stage for acute pain. The company was founded in 2009 and is based in Toronto, Canada.